By Karen Raubenheimer
It’s been 20 years since a paper in the journal Science showed the environmental accumulation of tiny plastic fragments and fibres. It named the particles “microplastics”.
The paper opened an entire research field. Since then, more than 7,000 published studies have shown the prevalence of microplastics in the environment, in wildlife and in the human body.
So what have we learned?
In short, microplastics are widespread, accumulating in the remotest parts of our planet. There is evidence of their toxic effects at every level of biological organisation, from tiny insects at the bottom of the food chain to apex predators.
Microplastics are pervasive in food and drink and have been detected throughout the human body. Evidence of their harmful effects is emerging.
The scientific evidence is now more than sufficient: collective global action is urgently needed to tackle microplastics – and the problem has never been more pressing.
Microplastic pollution is the result of human actions and decisions. We created the problem – and now we must create the solution.
Microplastics are generally accepted as plastic particles 5mm or less in one dimension.
Some microplastics are intentionally added to products, such as microbeads in facial soaps.
Others are produced unintentionally when bigger plastic items break down – for example, fibres released when you wash a polyester fleece jacket.
Science hasn’t yet determined the rate at which larger plastics break down into microplastics. They are also still researching how quickly microplastics become ‘nanoplastics’ – even smaller particles invisible to the eye.
In 2020 a study estimated between 0.8 and three million tonnes of microplastics enter Earth’s oceans in a year.
And a recent report suggests leakage into the environment on land could be three to ten times greater.
The news gets worse. By 2040, microplastic releases to the environment could more than double. Even if humans stopped the flow of microplastics into the environment, the breakdown of bigger plastics would continue.
Microplastics have been detected in more than 1,300 animal species, including fish, mammals, birds and insects.
Microplastics have been identified in the water we drink, the air we breathe and the food we eat – including seafood, table salt, honey, sugar, beer and tea.
Sometimes the contamination occurs in the environment. Other times it’s the result of food processing, packaging and handling.
As equipment has advanced, scientists have identified smaller particles. They’ve found microplastics in our lungs, livers, kidneys, blood and reproductive organs. Microplastics have crossed protective barriers into our brains and hearts.
While we eliminate some microplastics through urine, faeces and our lungs, many persist in our bodies for a long time.
So what effect does this have on the health of humans and other organisms?
The nature of microplastics differs. For example, they contain different chemicals and interact differently with liquids or sunlight. And species of organisms, including humans, themselves vary between individuals.
This complicates scientists’ ability to conclusively link microplastics exposure with effects.
In regards to humans, progress is being made. In coming years, expect greater clarity about effects on our bodies such as: inflammation, oxidative stress, immune responses and genotoxicity.
Public concern about microplastics is growing. This is compounded by our likely long-term exposure, given microplastics are almost impossible to remove from the environment.
Some countries have implemented laws regulating microplastics. But this is insufficient to address the challenge. That’s where a new legally binding agreement, the UN’s Global Plastics Treaty, offers an important opportunity. The fifth round of negotiations begins in November.
The treaty aims to reduce global production of plastics. But the deal must also include measures to reduce microplastics specifically.
Ultimately, plastics must be redesigned to prevent microplastics being released. And individuals and communities must be brought on board, to drive support for government policies.
We have more than enough evidence to act now.
Karen Raubenheimer is Senior Lecturer, University of Wollongong. This article is republished from The Conversation under a Creative Commons licence
